Zymeworks
Zymeworks is a biopharmaceutical company focused on developing novel medicines for cancer and other serious diseases, utilizing advanced biotherapeutic technologies and engaging in global clinical trials.
Company Overview
Zymeworks specializes in developing novel medicines aimed at treating difficult-to-treat cancers and other serious diseases. The company utilizes revolutionary technologies to engineer biotherapeutics specifically designed for various purposes. They operate a fully integrated R&D engine that spans from target selection to pivotal studies, all aimed at addressing significant scientific challenges to deliver transformational therapies.
Technologies and Platforms
Zymeworks focuses on developing multifunctional therapeutics utilizing best-in-class platforms, including antibody-drug conjugates and multispecific antibody therapeutics technologies. These advanced platforms support their growing pipeline of novel therapies designed to target and treat complex diseases effectively.
Research and Development
Zymeworks operates a fully integrated research and development engine that oversees every stage from target selection to pivotal studies. This comprehensive R&D approach enables them to tackle significant scientific challenges and deliver transformational therapies for patients with serious diseases.
Clinical Trials
Engaging in clinical trials on a global scale, Zymeworks extensively tests their biotherapeutics to ensure safety and efficacy. These trials are a crucial part of their commitment to delivering cutting-edge treatments for patients facing serious health conditions.
Global Partnerships
Zymeworks has formed strategic partnerships to enhance the development and commercialization of its therapies. The company collaborates with Jazz Pharmaceuticals and BeiGene for the development and commercialization of zanidatamab, a promising therapeutic candidate. These partnerships play a significant role in advancing Zymeworks' mission to offer effective treatments.
Global Presence
Zymeworks maintains a global presence with offices in Vancouver, BC, Canada; Redwood City, CA, USA; Bellevue, WA, USA; Dublin, Ireland; and Singapore. This international footprint supports their extensive research, development, and commercialization activities, enabling them to bring innovative therapies to patients worldwide.